CMA Statement on Supreme Court's Decision Maintaining Mifepristone's FDA Approval
June 14, 2024
June 14, 2024
SACRAMENTO, California, June 14 -- The California Medical Association issued the following statement on June 13, 2024:
* * *
Tanya W. Spirtos, M.D., president of the California Medical Association (CMA), issued the following statement in response to the U.S. Supreme Court's decision in FDA v. Alliance for Hippocratic Medicine, which preserves the U.S. Food and Drug Administration's (FDA) approval of the abortion medication mifepristone:
"The . . .
* * *
Tanya W. Spirtos, M.D., president of the California Medical Association (CMA), issued the following statement in response to the U.S. Supreme Court's decision in FDA v. Alliance for Hippocratic Medicine, which preserves the U.S. Food and Drug Administration's (FDA) approval of the abortion medication mifepristone:
"The . . .